Active Ingredient: REPAGLINIDE
Proprietary Name: REPAGLINIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 0.5MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A207209
Product Number: 001
Approval Date: Mar 22, 2023
Applicant Holder Full Name: MACLEODS PHARMACEUTICALS LTD
Marketing Status:
Prescription
Patent and Exclusivity Information